# Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

> **NCT06235203** · PHASE3 · RECRUITING · sponsor: **Eye & ENT Hospital of Fudan University** · enrollment: 154 (estimated)

## Conditions studied

- Recurrent Nasopharyngeal Carcinoma

## Interventions

- **PROCEDURE:** endoscopic surgery
- **DRUG:** Neoadjuvant therapy,Toripalimab Injection and Gemcitabine based therapy
- **DRUG:** Adjuvant therapy in experimental group,Toripalimab Injection and Gemcitabine based therapy
- **DRUG:** Adjuvant therapy in control group,Toripalimab Injection and Gemcitabine based therapy

## Key facts

- **NCT ID:** NCT06235203
- **Lead sponsor:** Eye & ENT Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235203, "Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06235203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*